论文部分内容阅读
目的观察疏血通注射液治疗急性脑梗死疗效。方法 180急性脑梗死患者随机分为两组,均常规控制血压、颅压,对症支持治疗;对照组88例应用复方丹红注射液20ml加入5%葡萄糖注射液250ml中静脉滴注,1次/d,连用2周;治疗组92例给予疏血通8ml加入5%葡萄糖注射液250ml中静脉滴注,1次/d,连用2周。结果治疗组总有效率及神经功能缺损评分改善情况均较对照组差异有统计学意义(P<0.05),治疗过程中无不良反应发生。结论疏血通注射液治疗急性脑梗死临床疗效确切、安全。
Objective To observe the therapeutic effect of Shuxuetong injection on acute cerebral infarction. Methods A total of 180 acute cerebral infarction patients were randomly divided into two groups, all with routine control of blood pressure, intracranial pressure, symptomatic and supportive treatment. In the control group, 88 cases were treated with Fufang Danhong injection 20ml and 5ml dextrose injection 250ml intravenously, once / d, once every two weeks; treatment group 92 cases given Shuxuetong 8ml add 5% glucose injection 250ml intravenous infusion, 1 / d, once every 2 weeks. Results The total effective rate and the improvement of neurological deficit score in the treatment group were significantly different from those in the control group (P <0.05). No adverse reactions occurred during the treatment. Conclusion Shuxuetong injection in the treatment of acute cerebral infarction clinical efficacy is exact and safe.